Edition:
United States

Cryosite Ltd (CTE.AX)

CTE.AX on Australia Stock Exchange

0.14AUD
--
Change (% chg)

-- (--)
Prev Close
$0.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,839
52-wk High
$0.20
52-wk Low
$0.13

Latest Key Developments (Source: Significant Developments)

Cryosite says FY net profit for the period attributable $225,000
Wednesday, 23 Aug 2017 04:55am EDT 

Aug 23 (Reuters) - Cryosite Ltd :FY revenue from ordinary activities up 0.3% to $10.2 million.FY net profit for the period attributable to members down 25.5% to $225,000.  Full Article

Cryosite says ACCC to review proposed license and sale of certain cord blood and tissue assets​
Thursday, 3 Aug 2017 06:37pm EDT 

Aug 4 (Reuters) - Cryosite Ltd -:Australian competition & consumer commission to review proposed license and sale of certain cord blood and tissue assets​.Cryosite is considering its position in light of notification; proceeding with its plans to seek shareholder approval to proposed transaction​.  Full Article

Cryosite says Mark Byrne has been appointed interim CEO
Wednesday, 14 Jun 2017 08:08pm EDT 

June 15 (Reuters) - Cryosite Ltd ::Appointment of interim CEO.Mark Byrne, CFO, has been appointed interim CEO.Agreed with Andrew Shine (CEO), that his notice period will now be effective 30th June 2017.  Full Article

Cryosite announces resignation of ceo
Thursday, 18 May 2017 07:48pm EDT 

May 19 (Reuters) - Cryosite Ltd ::Andrew Shine has tendered his resignation as ceo.  Full Article

Cryosite appoints Andrew Shine as CEO
Wednesday, 8 Jun 2016 02:14am EDT 

Cryosite Ltd : Appointment of CEO .Appointment of Andrew Shine as chief executive officer for cyrosite ltd.  Full Article

Cryosite appoints Stephen Roberts as chairman
Sunday, 10 Apr 2016 08:45pm EDT 

Cryosite Ltd:Says Stephen Roberts has been appointed chairman of Cryosite effective 8th April 2016.Andrew Kroger, who will remain a non-executive director, has decided to step down as chairman.  Full Article

BRIEF-Cryosite says ACCC to review proposed license and sale of certain cord blood and tissue assets​

* Australian competition & consumer commission to review proposed license and sale of certain cord blood and tissue assets​

No consensus analysis data available.